Pascal Benkert
Universität Basel
H-index: 29
Europe-Switzerland
Top articles of Pascal Benkert
Complement activation is associated with disease severity in multiple sclerosis
Neurology: Neuroimmunology & Neuroinflammation
2024/2/14
Effects of obstructive sleep apnea treatment on neurodegenerative biomarker neurofilament light chain and cognitive performance
Journal of Sleep Research
2024/2/13
Pascal Benkert
H-Index: 18
Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis
Annals of Clinical and Translational Neurology
2024/2
Serum neurofilament light and white matter characteristics in the general population: a longitudinal analysis
Geroscience
2024/2
Association of spinal cord atrophy and brain paramagnetic rim lesions with progression independent of relapse activity in people with MS
Neurology
2024/1/9
MultiSCRIPT-Cycle 1-A Pragmatic trial embedded within the Swiss Multiple Sclerosis Cohort (SMSC) on neurofilament light chain monitoring to inform personalized treatment …
medRxiv
2024
Polygenic risk for Alzheimer's disease is associated with neuroaxonal damage before onset of clinical symptoms
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
2024/1
Stephan Ripke
H-Index: 88
Pascal Benkert
H-Index: 18
Escalating to medium-versus high-efficacy disease modifying therapy after low-efficacy treatment in relapsing remitting multiple sclerosis
Brain and behavior
2024/5
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis
Journal of Neurology, Neurosurgery & Psychiatry
2024/5/1
Granulocyte Activation and Astrocyte Damage Markers in CSF Differentiate Acute NMOSD and MOGAD from MS (P9-14.004)
2024/4/14
Serum neurofilament light as a potential marker of illness duration in bipolar disorder
Journal of Affective Disorders
2024/4/1
Blood donation for iron removal in individuals with HFE mutations: study of efficacy and safety and short review on hemochromatosis and blood donation
2024/3/19
Efficacy and safety results after> 3.5 years of treatment with the Bruton’s tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a …
Multiple Sclerosis Journal
2024/3/4
Pascal Benkert
H-Index: 18
Jamie Shaw
H-Index: 2
Identification of paramagnetic rim lesions using conventional MRI: a deep learning approach
Multiple Sclerosis Journal
2023
Pascal Benkert
H-Index: 18
Andrew Chan
H-Index: 15
Serum neurofilament light chain (NfL) levels in children with and without neurologic diseases
European Journal of Paediatric Neurology
2023/7/1
Pascal Benkert
H-Index: 18
Serum neurofilament light chain cut‐off definition for clinical diagnosis and prognosis of amyotrophic lateral sclerosis
European Journal of Neurology
2023/7
Pascal Benkert
H-Index: 18
Christophe Hirtz
H-Index: 21
William Camu
H-Index: 39
Sylvain Lehmann
H-Index: 37
Explainable Artificial Intelligence to predict clinical outcomes in type 1 diabetes and relapsing-remitting multiple sclerosis adult patients
Informatics in Medicine Unlocked
2023/1/1
Concentrations of Serum Brain Injury Biomarkers Following SARS-CoV-2 Infection in Individuals with and without Long-COVID—Results from the Prospective Population-Based COVI …
Diagnostics
2023/6/26
Pascal Benkert
H-Index: 18
David Conen
H-Index: 43
Neurofilament light chain NfL zur individuellen Diagnostik und Prognose von Hirnschädigungen im Kindesalter: eine retrospektive Modellierungs-und Validierungsstudie
Zeitschrift für Geburtshilfe und Neonatologie
2023/6
Pascal Benkert
H-Index: 18
High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis
European Journal of Neurology
2023/5
Pascal Benkert
H-Index: 18
